Lantheus says CMS grants transitional pass-through status for PYLARIFY TruVu effective Oct. 1
LNTH•CMS granted PYLARIFY TruVu transitional pass-through payment status and a permanent HCPCS code, both effective Oct. 1, 2026, enabling separate Medicare reimbursement in hospital outpatient settings.
1. Reimbursement status granted
CMS granted transitional pass-through payment status for PYLARIFY TruVu, effective Oct. 1, 2026. The status enables separate Medicare reimbursement for the product in hospital outpatient settings, and CMS assigned a permanent HCPCS code effective the same date.
